Catalyst
Slingshot members are tracking this event:
Vanda Pharmaceuticals (VNDA) Expected to submit HETLIOZ filing to FDA in 2018 for Non-24 sleep-wake disorder pediatric indication
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VNDA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 19, 2019
Occurred Source:
https://www.fiercebiotech.com/biotech/fda-snubs-jet-lag-filing-for-vanda-s-sleep-disorder-med-hetlioz
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Non-24-hour Sleep-wake Disorder, Hetlioz, Fda Review, Pediatric
